A human CD4+ t-cell line expresses functional CD64 (FcγRI), CD32 (FcγRII), and CD16 (FcγRIII) receptors but these do not enhance the infectivity of HIV-1-IgG complexes

Immunology

Volumn 90, Issue 1, 1997, Pages 109-114

  Mclain, L ^a   Dimmock, N J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN G;

ARTICLE; CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031025051     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00116.x     Document Type: Article

References (29)

1. UNKELESS J.C., SCIGLIANO E & FREEDMAN V.H. (1988) Structure and function of human and murine receptors for IgG. Ann Rev Immunol 6, 251.
2. BURTON D.R. & WOOF J.M. (1992) Human antibody effector function. Adv Immunol 51, 1.
3. VAN DE WINKEL J.G.J. & CAPEL P.J.A. (1993) Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 14, 215.
4. DICKLER H.B. (1976) Lymphocyte receptors for immunoglobulin. Adv Immunol 24, 167.
5. LANIER L.L., KIPPS T.J. & PHILLIPS J.H. (1985) Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/leu-11 antigen). J Exp Med 162, 2089.
6. MATHUR A., LYNCH R.G. & KöHLER G. (1988) The contribution of constant region domains to the binding of murine IgM to Fcμ recepors on T cells. J Immunol 140, 143.
7. LYNCH R.G. & SANDOR M. (1990) Fc receptors on T and B lymphocytes. In: Fc receptors and the action of antibodies (ed. H. Metzger), p305. American Society for Microbiology, Washington, DC.
8. SANDOR M. & LYNCH R.G. (1993) Lymphocyte Fc receptors: the special case of T cells, Immunol Today 14, 227.
9. GESSNER J.E., GRUSSENMEYER T. & SCHMIDT R.E. (1995) Differentially regulated expression of human IgG Fc receptor class II genes. Immunobiology 193, 341.
10. ENGELHARDT W., MATZKE J. & SCHMIDT R.E. (1995) Activation-dependent expression of low affinity IgG receptors FcγRII (CD32) and FcγRIII (CD16) in subpopulations of human T lymphocytes. Immunobiology 192, 297.
11. NEAUPORT-SAUTES C., DAERON M., TEILLARD, J.-L., BLANK U. & FRIDMAN W.H. (1986) The occurrence, structural and functional properties of immunoglobulin Fc receptors on murine neoplastic cells. Intern Rev Immunol 1, 237.
12. SALAHUDDIN S.Z., MARKHAM P.D., WONG-STAAL F., FRANCHINI G., KALYANARAMAN V.S. & GALLO R.C. (1983) Restricted expression of human T-cell leukaemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129, 51.
13. LEE T.H., COLIGAN J.H., SODROSKI J. et al. (1984) Antigens encoded by the 3′-terminal region of human T-cell leukaemia virus: evidence for a functional gene. Science 226, 57.
14. POPOVIC M., SARNGADHARAN M.G., READ E. & GALLO R.C. (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497.
15. POSNER M.R., HIDESHIMA T., CANNON T., MUKHERJEE M., MAYER K.H. & BYRN R.A. (1991) An IgG human monoclonal antibody that reacts with HIV-1/gp120, inhibits virus binding to cells, and neutralizes infection. J Immunol 146, 4325.
16. THIRIART C., FRANCOTTE M., COHEN J. et al. (1989) Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120. J Immunol 143, 1832.
17. WANG B., AGADJANYAN M.G., SPIKANTAN V. et al. (1993) Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II induced cell fusion. AIDS Res Hum Retroviruses 9, 849.
18. Cosio F.G., ACKERMAN S.K., DOUGLAS S.D., FRIHND P.S. & MICHAEL A.F. (1981) Soluble immune complexes binding to human monocytes and polymorphonuclear leucocytes. Immunology 44, 773.
19. MCLAIN L. & DIMMOCK N.J. (1994) Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. J Gen Virol 75, 1457.
20. DIMMOCK N.J., MCINERNEY T.L., CORDELL J. et al. (1996) Six HIV-1 gp120-specific monoclonal antibodies exhibit two mechanisms of neutralization: inhibition of attachment to the CD4 receptor is not one of them. In: Vaccine 96 (ed. F. Brown, D. R. Burton. J. Collier, J. Mekalonos & E. Norrby), pp. 143 148. Cold Spring Harbor Laboratory, NY.
21. MORENS D.M. & HALSTEAD S.B. (1990) Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol 71, 2909.
22. MASCOLA J.R., MATHIESON B.J., ZACK P.M., WALKER M.C., HALSTEAD S.B. & BURKE D.S. (1993) Summary report: workshop on the potential risks of antibody-dependent enhancement in human vaccine trials. AIDS Res Hum Retroviruses 9, 1175.
23. BOLOGNESI D. (1989) Do antibodies enhance the infection of cells by HIV? Nature 340, 431.
24. ARMSTRONG S.J., MCINERNEY T.L., MCLAIN L. et al. (1996) Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type. J Gen Virol. in press.
25. HO D.D., KAPLAN J.C., RACKAUSKAS I.E. & GURNEY M.E. (1988) Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science 239, 1021.
26. MCDOUGAL J.S., NICHOLSON J.K.A., CROSS G.D., CORT S.P., KENNEDY M.S. & MAWLE A.C. (1986) Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol 137, 2937.
27. MONTEFIORI D.C., GRAHAM B.S., ZHOU J., BUCCO R.A., SCHWARTZ D.M., CAVACINI L.A., POSNER M.R., NIH-NAIAD AIDS VACCINE CLINICAL TRIALS NETWORK (1993) V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp12 Clin Invest 92, 840.
28. SKINNER M.A., LANGLOIS A.J., MCDANAL C.B., MCDOUGAL J.S., BOLOGNESI D.P. & MATTHEWS T.J. (1988) Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD Virology 62, 4195.
29. SUN, N.-C. HO D.D. SUN C.R.Y. (1989) Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. J Virol 63, 3579.